SGLT2 Inhibitors Linked to Cardiorenal Benefits Across CKM Syndrome Stages 2–4
A large analysis of clinical-trial evidence suggests that sodium-glucose cotransporter 2 (SGLT2) inhibitors protect the heart and kidneys across multiple ...
Tag: SGLT2 inhibitors
Generic semaglutide availability may lower barriers to affordable diabetes care
Generic semaglutide is starting to rewrite the economics of type 2 diabetes care in Canada. A new analysis published in ...
Kidney Disease Rates Stable, Increasing Among Diabetes and Heart Patients in US
Chronic kidney disease (CKD) remains a pervasive and silent health threat in the United States, affecting approximately 15% of adults ...
Tofogliflozin vs. Metformin: Impact on Diabetic Kidney Disease
In a significant advancement in the management of diabetic kidney disease (DKD), researchers have initiated the TRUTH-DKD trial, which aims ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!